Market cap
$170.455 B
$29.91 -2.87%
Close of 6 Nov 2026
As of 6 Nov 2026, Pfizer (PFE) has a market capitalization of $170.5B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$62.6B
#65 by revenue
Earnings
$7.77B
#60 by earnings
Shares outstanding
5,699,853,733
Latest filing cover page
P/E ratio
21.9
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 498 →- #7Abbott LaboratoriesABT$197.0B
- #8Novo Nordisk A SNVO$178.7B
- #9PfizerPFE$170.5B
- #10Vertex PharmaceuticalsVRTX$137.7B
- #11Bristol Myers SquibbBMY$129.3B
What if Pfizer were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Pfizer are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.